BENITEC BIOPHARMA

In News

Benitec Biopharma (NASDAQ: BNTC) director gifts 51,813 shares to donor-advised fund - Stock Titan

Stock Titan - Jun 30, 2026

Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia - CGTLive®

CGTLive® - Apr 19, 2026

Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Yahoo Finance

Yahoo Finance - Feb 14, 2026

BNTC Forecast — Price Target — Prediction for 2027 - TradingView

TradingView - Jun 25, 2026

Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting - GlobeNewswire

GlobeNewswire - Apr 28, 2026

Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade - Seeking Alpha

Seeking Alpha - Jan 31, 2026

Mintz Advises on Benitec Biopharma’s $80 Million Follow-On Offering and Concurrent $20 Million Registered Direct Offering - Mintz

Mintz - Nov 12, 2025

Benitec Biopharma Inc.(NasdaqCM:BNTC) added to Russell Small Cap Comp Value Benchmark - marketscreener.com

marketscreener.com - Jun 28, 2026

Benitec Biopharma’s SWOT analysis: gene therapy stock shows clinical promise - Investing.com

Investing.com - May 25, 2026

Swallowing improves for 4 OPMD patients after new gene therapy - Muscular Dystrophy News

Muscular Dystrophy News - Feb 19, 2026

Jerel A. Banks, MD, PhD, on Evaluating Gene Therapy BB-301 for OPMD-Related Dysphagia - CGTLive®

CGTLive® - Mar 13, 2026

Benitec Biopharma Inc (BNTC) Institutional Confidence - TradingKey

TradingKey - Jun 18, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment